Clinical Trials in Detroit

Showing 881-900 of 19,719 trials

Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation

NCT04700098

This study is a randomized controlled trial (RCT) to compare sleep and health-related functioning in Veterans with chronic obstructive pulmonary disease (COPD) and insomnia receiving an Internet-based behavioral treatment for insomnia versus online insomnia patient education. Participants will undergo a sleep and health assessment that will be performed at baseline, post-treatment, and 3-months later. Participants will be randomly assigned to either Internet-based behavioral treatment for insomnia or online insomnia patient education.

Chronic Obstructive Pulmonary DiseaseInsomnia

VA Office of Research and Development13 participantsStarted Feb 2022

Detroit, Michigan, United States • Pittsburgh, Pennsylvania, United States

RECRUITINGPhase 4< 1 mile

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

NCT06057402

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.

Multiple Myeloma

Pfizer80 participantsStarted Oct 2023

Fort Collins, Colorado, United States • Fort Collins, Colorado, United States • Greeley, Colorado, United States +25 more locations

Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Find Trials by Condition in Detroit

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Strength or Power Training for Patellofemoral Pain

PD, PK, and Safety of ALTO-203 in Patients With MDD

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

Natural History Study of Patients With Canavan Disease (CANinform Study)

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial